6632--INTENT TO SOLE SOURCE LAB BLOOD GAS TESTING CPT to WERFEN USA, LLC at VA NEW YORK HARBOR 36C24225Q0942
Summary
AI-generated · Aug 24, 2025The VA New York Harbor Healthcare System intends to award a sole-source, firm-fixed-price, five-year BPA to Werfen USA, LLC for blood gas testing equipment and related consumables on a reagent rental, cost-per-test basis. The project covers testing at both Brooklyn and Manhattan ancillary sites and in core laboratories, with testing performed by both laboratory professionals and ancillary clinical staff. A key requirement is reliable detection of specimen problems (especially hemolysis) with a hard-stop that prevents reporting of invalid results. The Werfen Gem 7000 analyzer is highlighted as the only system capable of detecting hemolysis in patient whole blood, grading its severity, and applying programmable thresholds to hold results when needed, thereby expected to improve result reliability and patient care. This is not a competitive solicitation.
Modification 1 updates the notice to remove unsuitable wording and changes the response deadline to August 27, 2025. It reiterates the sole-source, five-year BPA to Werfen USA, LLC for consumables and supplies needed to support a reagent rental, cost-per-test contract, and again states that the Gem 7000’s hemolysis detection capabilities are central to meeting VA needs. The notice remains non-competitive, with responses by the new deadline considered for future procurements; the government will not pay for information submitted. This is the only notice of the government’s intent to solicit, negotiate, and award to a single source.
The Department of Veterans Affairs, New York Harbor Healthcare System at Margaret Cochran Corbin VA Medical Center and Brooklyn VA Medical Center (VISN 2 South), intends to award a sole-source, firm fixed-price, open market, five-year BPA to Werfen USA, LLC, in accordance with FAR Subpart 13.303-2. The acquisition sought is a BPA that will cover consumables and supplies needed to produce a reagent rental, cost per test contract. The NAICS is 334516 with a small business size standard of 1,000 employees. PSC is 6632. New York Harbor Pathology and Laboratory Medicine Service requires state-of-the-art blood gas analyzers to perform testing both at ancillary sites on the Brooklyn and Manhattan campuses, and in the core laboratories. The needs of VA New York Harbor are unique because testing will be performed by both laboratory professionals and ancillary clinical staff. The performance of the test by ancillary clinical staff introduces the opportunity for error that has plagued our current platform. As such it is imperative that our new analyzers are capable of detecting problems with specimens and implementing a hard stop that prevents the reporting of results that are not valid. The most common problem with these specimens is hemolysis. The Werfen Gem 7000 is the only analyzer on the market capable of detecting hemolysis in patient whole blood specimens. Not only can it detect hemolysis, but it can also grade its severity and apply rules that hold results if it exceeds a programmable threshold. The point of care analyzers we currently have in place are often reporting erroneous results causing confusion for providers and delaying care for patients. VA New York Harbor is confident that the Werfen Gem 7000 analyzer will significantly improve the reliability of our results and meet the needs of our veteran patients. This notice of intent is not a request for competitive proposals and no solicitation will be made available. Any responses received no later than COB August 19, 2025 will be considered for the purposes of determining sources for future procurements. The Government will not pay for information submitted. Any information submitted in response to this notice of intent is strictly voluntary. This will be the only notice of the Government's intent to solicit, negotiate, and award to one source to satisfy this requirement.
From Special Notice posted on Aug 05, 2025Modification 1: The narrative has been edited to remove some unsuitable wording The response date was changed to August 27, 2025. The Department of Veterans Affairs, New York Harbor Healthcare System at Margaret Cochran Corbin VA Medical Center and Brooklyn VA Medical Center (VISN 2 South), intends to award a sole-source, firm fixed-price, open market, five-year BPA to Werfen USA, LLC, in accordance with FAR Subpart 13.303-2. The acquisition sought is a BPA that will cover consumables and supplies needed to produce a reagent rental, cost per test contract. The NAICS is 334516 with a small business size standard of 1,000 employees. PSC is 6632. New York Harbor Pathology and Laboratory Medicine Service requires state-of-the-art blood gas analyzers to perform testing both at ancillary sites on the Brooklyn and Manhattan campuses, and in the core laboratories. The needs of VA New York Harbor are unique because testing will be performed by both laboratory professionals and ancillary clinical staff. As such it is imperative that our new analyzers are capable of detecting problems with specimens and implementing a hard stop that prevents the reporting of results that are not valid. The most common problem with these specimens is hemolysis. The Werfen Gem 7000 is the only analyzer on the market capable of detecting hemolysis in patient whole blood specimens. Not only can it detect hemolysis, but it can also grade its severity and apply rules that hold results if it exceeds a programmable threshold. This notice of intent is not a request for competitive proposals and no solicitation will be made available. Any responses received no later than 15:00 August 27, 2025 will be considered for the purposes of determining sources for future procurements. The Government will not pay for information submitted. Any information submitted in response to this notice of intent is strictly voluntary. This will be the only notice of the Government's intent to solicit, negotiate, and award to one source to satisfy this requirement.
From Special Notice posted on Aug 20, 2025Notice history
3-
Special Notice Posted Aug 05, 2025
-
Special Notice Posted Aug 20, 2025View changes (4)
- Title: 6632--INTENT TO SOLE SOURCE LAB BLOOD GAS TESTING CPT to WERFEN USA, LLC at VA NEW YORK HARBOR → 6632--MODIFICATION TO NOTICE 36C24225Q0942 - INTENT TO SOLE SOURCE BLOOD GAS TESTING TO WERFEN USA AT VA NEW YORK HARBOR
- Description: Description was updated
- Response Deadline: Aug 19, 2025 → Aug 27, 2025
- Set-Aside: None → None
-
Award Notice LATEST Posted Oct 29, 2025
Details
Award Information
Awardees
| Company Name | UEI | CAGE Code | Location |
|---|---|---|---|
| WERFEN USA LLC | JA87HT8KP2M2 | 22270 | BEDFORD |
Contacts
Contracting Officer
Phone